Georgia vs Jordan: Cancer death rates in children under 10 years old
Georgia
1.63 deaths per 100,000 people
in 2023
Jordan
1.61 deaths per 100,000 people
in 2018
Georgia rank
80th
Jordan rank
81st
Cancer death rates in children under 10 years old over time
- Georgia
- Jordan
How they compare
Georgia currently reports 1.63 deaths per 100,000 people against 1.61 deaths per 100,000 people in Jordan, a difference of 0.02 deaths per 100,000 people.
The two have swapped places 2 times across 8 shared years of data; in 2009 it was Georgia ahead.
Georgia ranks 80th and Jordan ranks 81st of 110 countries.
Georgia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.52 deaths per 100,000 people | 2.07 deaths per 100,000 people | 3.45 deaths per 100,000 people | Georgia |
| 2010s | 3.03 deaths per 100,000 people | 1.5 deaths per 100,000 people | 1.52 deaths per 100,000 people | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rates in children under 10 years old, Georgia or Jordan?
- Georgia, at 1.63 deaths per 100,000 people against 1.61 deaths per 100,000 people in Jordan as of 2023.
- What is the difference in cancer death rates in children under 10 years old between Georgia and Jordan?
- 0.02 deaths per 100,000 people, with Georgia ahead.
- How many years of comparable data are there for Georgia and Jordan?
- 8 years are reported by both, from 2009 to 2018.
- How do Georgia and Jordan rank globally for cancer death rates in children under 10 years old?
- Georgia ranks 80th and Jordan ranks 81st of 110 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rates in children under 10 years old. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged 10-14 years.